Related Experiment Videos
[Tiagabine and non-convulsive status epilepticus]
M Holtkamp1, M Pfeiffer, K Buchheim
1Neurologische Klinik und Poliklinik, Universitätsklinikum Charité, Humboldt-Universität zu Berlin.
Der Nervenarzt
|January 19, 2000
Summary
High doses of the anticonvulsant tiagabine may cause nonconvulsive status epilepticus (NCSE). A patient developed NCSE after starting tiagabine, suggesting a causal link due to impaired GABA inhibition.
Area of Science:
- Neurology
- Pharmacology
Background:
- Nonconvulsive status epilepticus (NCSE) is a neurological emergency.
- Tiagabine is an anticonvulsant medication used to treat epilepsy.
- Adverse effects of anticonvulsants require careful monitoring.
Observation:
- A patient with no prior history of status epilepticus developed NCSE.
- NCSE occurred shortly after the administration of higher doses or dose increases of tiagabine.
Findings:
- A causal relationship between tiagabine and NCSE is strongly suggested.
- Experimental studies indicate that high tiagabine doses can disrupt GABAergic inhibition by altering glial and neuronal GABA uptake.
Implications:
- Clinicians should be aware of the risk of tiagabine-induced NCSE.
- Careful dose titration and monitoring are recommended when prescribing tiagabine.
- Further research into the mechanisms of tiagabine neurotoxicity is warranted.